99 related articles for article (PubMed ID: 2559489)
21. Factor IX deficiency in Gaucher disease. An in vitro phenomenon.
Boklan BF; Sawitsky A
Arch Intern Med; 1976 Apr; 136(4):489-92. PubMed ID: 1267559
[TBL] [Abstract][Full Text] [Related]
22. [Substitution therapy of coagulopathies].
Beeser H; Egli H
Infusionstherapie (1973); 1974 Aug; 1(6):447-53. PubMed ID: 4466806
[No Abstract] [Full Text] [Related]
23. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
Girolami A; Dal Bo Zanon R; Procidano M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
[TBL] [Abstract][Full Text] [Related]
24. Factor IX Deventer-evidence for the heterogeneity of hemophilia BM.
Bertina RM; van der Linden IK
Thromb Haemost; 1982 Apr; 47(2):136-40. PubMed ID: 7101232
[TBL] [Abstract][Full Text] [Related]
25. Immune reactive factor IX in acquired factor IX deficiency.
Lechner K
Thromb Diath Haemorrh; 1972 Feb; 27(1):19-24. PubMed ID: 5033668
[No Abstract] [Full Text] [Related]
26. Studies on Christmas disease: investigation and treatment of a familial acquired inhibitor of factor IX.
George JN; Miller GM; Breckenridge RT
Br J Haematol; 1971 Sep; 21(3):333-42. PubMed ID: 4998792
[No Abstract] [Full Text] [Related]
27. Evaluation of a new concentrate for the treatment of factor IX deficiency.
Gilchrist GS; Ekert H; Shanbrom E; Hammond D
N Engl J Med; 1969 Feb; 280(6):291-5. PubMed ID: 5762370
[No Abstract] [Full Text] [Related]
28. Studies on the prolonged prothrombin time in haemophilia BM.
Elödi S
Thromb Diath Haemorrh; 1973 May; 29(2):247-52. PubMed ID: 4796945
[No Abstract] [Full Text] [Related]
29. Physiologic considerations in the management of hemophilia.
Briggs DK
Pathobiol Annu; 1971; 1():205-14. PubMed ID: 4950380
[No Abstract] [Full Text] [Related]
30. [Clinical significance of factor IX analysis in blood coagulation tests].
Kakishita E; Nishida Y
Nihon Rinsho; 1989 Dec; 48 Suppl():834-6. PubMed ID: 2622013
[No Abstract] [Full Text] [Related]
31. Factor IX Zutphen. A genetic variant of blood coagulation factor IX with an abnormally high molecular weight.
Bertina RM; Van Der Linden IK
J Lab Clin Med; 1982 Nov; 100(5):695-704. PubMed ID: 7130828
[TBL] [Abstract][Full Text] [Related]
32. A quantitative two-stage assay for factor IX (Christmas factor) using plasma from dogs with Christmas disease.
Aronson DL; Dodds WJ; Mustafa AJ
Thromb Diath Haemorrh; 1972 Jul; 27(3):529-34. PubMed ID: 4662614
[No Abstract] [Full Text] [Related]
33. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
Carmassi F; Giannarelli C; De Giorgi A; De Negri F
Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
[TBL] [Abstract][Full Text] [Related]
34. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
[TBL] [Abstract][Full Text] [Related]
35. A rare case of an acquired inhibitor to factor IX.
Krishnamurthy P; Hawche C; Evans G; Winter M
Haemophilia; 2011 Jul; 17(4):712-3. PubMed ID: 21371188
[No Abstract] [Full Text] [Related]
36. Bleeding symptoms in carriers of hemophilia A and B.
Mauser Bunschoten EP; van Houwelingen JC; Sjamsoedin Visser EJ; van Dijken PJ; Kok AJ; Sixma JJ
Thromb Haemost; 1988 Jun; 59(3):349-52. PubMed ID: 2847347
[TBL] [Abstract][Full Text] [Related]
37. [Factor IX inhibitor (antihemophilic factor B, PTC) in a woman].
Hule V
Vnitr Lek; 1975 Mar; 21(3):274-7. PubMed ID: 1119107
[No Abstract] [Full Text] [Related]
38. [Analysis of F.IX-inhibitor bypassing activity contained in a commercial prothrombin complex concentrate (Proplex)].
Sugimoto M; Fujimura Y; Okubo Y; Takahashi Y; Yoshioka A; Fukui H
Nihon Ketsueki Gakkai Zasshi; 1984 Aug; 47(5):1181-9. PubMed ID: 6516702
[No Abstract] [Full Text] [Related]
39. Acquired inhibitors of blood coagulation.
Feinstein DI; Rapaport SI
Prog Hemost Thromb; 1972; 1():75-95. PubMed ID: 4569725
[No Abstract] [Full Text] [Related]
40. [Thromboplastin generation test and possible errors in its reproducibility].
Tarasova LN
Lab Delo; 1980; (11):669-71. PubMed ID: 6160299
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
